Abstract. Recent studies have found aberrant expression of class II antigens by bronchial epithelial cells (BECs), suggesting that these cells may also be involved in airway mucosal immunity. However, the regulation of class II antigen expression on BECs by cytokines and the functional capacity of such cells bearing class II molecules remain unknown. We investigated the effect of IFN-~/on class II antigen expression by cultured rat BECs, as well as the ability of these cells to present intact protein antigens to specifically sensitized T cells, Although primary BECs did not express class II antigens, IFN-~/readily induced their expression in a dose-dependent manner. More than 85% of the BECs treated with 1000 U/ml of IFN-~/were positive for class II antigens. In addition, when IFN-treated BECs bearing class II molecules were pulsed with ovalbumin (OVA), they significantly stimulated the proliferation of OVA-sensitized T cells, whereas cells that were not treated with IFN--y but were pulsed with OVA did not do so. Our findings indicate that BECs bearing class II molecules are capable of presenting OVA to OVA-sensitized T cells. These results suggest that various pathological conditions causing the local production of IFN-~t may increase class II antigen expression on BECs, which in turn may modulate the airway mucosal immune response by the presentation of antigens to T ceils.
Introduction
The bronchial epithelium is known to provide a major physiological barrier against inhaled particles or pathogens. In addition, recent studies have revealed that bronchial epithelial cells (BECs) are able to produce various mediators and cytokines [15, 20, 23, 32] . The data obtained suggest that BECs directly affect the function of resident pulmonary cells or inflammatory cells, thereby modulating the local immune response and contributing to the pathogenesis of some inflammatory lung diseases.
Major histocompatibility complex (MHC) class II antigens are normally expressed by immunocompetent cells, such as activated T cells, B cells, monocytes, macrophages, and dendritic cells, which play a crucial role in initiation of the immune response by presenting antigens to helper T cells. Recent studies have demonstrated the aberrant expression of class II antigens by epithelial cells in several tissues [8, 16, 21] , including human BECs [7, 25] , suggesting that these cells may be involved in mucosal immunity. It is also known that some of these cells fail to stimulate T cells despite their expression of class II antigens, indicating that this class II antigen expression is insufficient to ensure antigen-presenting cell (APC) function [4, 22, 30] . In this context, in remains unclear how class II antigen expression on BECs is modulated by cytokines and whether or not BECs bearing class II molecules are able to function as APC.
To clarify these points, we investigated the effect of interferon-gamma (IFN-~/) on class II antigen expression by cultured rat BECs. In addition, the ability of BECs to present an intact protein antigen to specifically sensitized T cells was explored. The present study showed that primary cultured BECs were negative for class II antigens, whereas IFN--~ readily induced the expression of these antigens. Furthermore, BECs bearing class II molecules were capable of presenting ovalbumin (OVA) to OVA-sensitized T cells. These results suggest that BECs can be induced to act as APC and may modulate the airway mucosal immune response.
Materials and Methods

Animals
Specific pathogen-free male Fisher 344 rats, weighing 200-250 g, were purchased from the Shizuoka Agricultural Cooperative Association for Laboratory Animals (Shizuoka, Japan) for use in this study.
Isolation of Rat BECs
BECs were prepared by a modification of the method of Wu and coworkers [34] . Briefly, rats were injected intraperitoneally with sodium pentobarbital and sacrificed by exsanguination via the abdominal aorta. The trachea was then excised from each rat and filled with 0.1% protease type XIV (Sigma, St. Louis, MO) in Ham's F12 medium (Gibco, Grand Island, NY). Following incubation overnight at 4~ the dissociated cells were collected by flushing out each trachea with Ham's F12 medium containing 10% fetal bovine serum (FBS). The cells were then filtered through a 100-p.m nylon mesh and resuspended in the same medium after two washings. This procedure yielded about 7 • 105 BECs per trachea, with over 85% viability being confirmed by the trypan blue exclusion test.
Culture of BECs
BECs were plated at a density of 2 x 105 ceils/dish 1 on 35-mm tissue culture dishes coated with 0.3% collagen gel (Vitrogen-100, Collagen Corp., Palo Alto, CA). Cells were grown in 2 ml of serum-free Ham's F12 medium supplemented with the following reagents: 5 I~g/ml bovine insulin (Sigma), 5 i~g/ml human transferrin (Sigma), 0.5 g.g/ml hydrocortisone (Sigma), 25 ng/ml epidermal growth factor (Sigma), 50 ~g/ml bovine pituitary extracts (Pel Freeze, Roger, AR), 40 ng/ml cholera toxin (Sigma), 0.1 ~M retinoic acid (Sigma), 15 mM Hepes buffer (Gibco), I00 U/ml penicillin (Gibco), and 100 I~g/ml streptomycin (Gibco). The BECs were incubated in a humidified atmosphere of 5% CO2 at 37~ The medium was initially changed at 24 hours and then every 48 hours subsequently. Cultured cells were confirmed to be epithelial in nature by immunocytochemical staining and electron microscopy. Cytokeratin was identified by immunoperoxidase staining using a polyclonal antibody (L1824; Dako, Carpinteria, CA). To rule out contamination with macrophages, nonspecific esterase staining with ct-naphtyl acetate (Sigma) were performed.
Induction and Quantification of MHC Class H Antigen Expression by Cultured BECs
BECs were allowed to grow to near confluence, after which rat recombinant IFN-7 (Holland Biotechnology, Leiden, The Netherlands) was added at the indicated concentrations for various periods of time. For flow cytometric analysis, the cultures were digested for 60 minutes at 37~ with 50 U/ml collagenase (Nitta Gelatin, Osaka, Japan), followed by treatment for 30 minutes with 0.5% trypsin and 0.5 mM EDTA (ethylenediaminetetra-acetate) (Gibco). This resulted in complete digestion of substratum and separation of the BECs. Approximately 1 • 105 dissociated cells were placed in a soft plastic tube (Falcon, Oxnard, CA) and incubated for 60 minutes at 4~ with a 1:20 dilution of antirat Ia mAb (Ox6; Serotec, Kidlington, UK) in phosphate buffered saline (PBS) containing 2% bovine serum albumin (BSA) (Sigma). After two rinses with the medium, the BECs were incubated for 60 minutes at 4~ with a 1:50 dilution of FITC-conjugated rabbit antimouse immunoglobulin (Ig) (Serotec). After fixing with 1% paraformaidehyde in PBS, flow cytometric analysis of the BECs was performed with an EPICS SCAN (Coulter Electronics, London, UK). Nonspecific background staining was determined using a control FITC-conjugated isotype antibody (IgG1, Coulter).
Immunocytochemical staining was performed using the avidin-biotin complex (ABC) technique. Briefly, the dissociated cells were cytocentrifuged on slides, pretreated with 2% normal horse serum, and incubated for 30 minutes at room temperature with a 1:1000 dilution of mAb Ox6 in PBS containing 2% BSA. After washing with PBS, the slides were incubated with biotinized horse F(ab')2 antimouse IgG (Vector, Burlingame, CA), and then the avidin-biotin complex (Vector) was added. After a final wash, the horseradish peroxidase was visualized with a 3,3-diaminobenzidine (DAB) solution containing hydrogen peroxidase (Vector).
T-Cell Preparation
Fisher rats were immunized in each footpad with 100 ~g of OVA (Grade VII, Sigma) emulsified in Freund's complete adjuvant (Difco Laboratories, Detroit, MI), and the draining popliteal and inguinal lymph nodes were excised 14-28 days later. Single cell suspensions of the lymph nodes were prepared by mechanical disaggregation using a steel mesh. To eliminate adherent cells and to enrich the T ceils, the cell suspensions were incubated for 60 minutes at 37~ on 100-ram tissue culture dishes in RPMI 1640 medium (Gibco) containing 10% FBS, and subsequently the nonadherent cells were passed through a goat antirat Ig-coated affinity column (Biotecx Laboratories, Houston, TX). The final cell population consisted of more than 95% T cells, as judged by the reaction with mAb Ox19 (Serotec) that recognizes rat T cells. In addition, these procedures archived a cell viability of more than 95%.
Antigen-Presenting Assay
IFN-treated or untreated BECs were pulsed with the indicated concentrations of OVA at 37~ for 16 hours and then washed three times with the medium. The cultures were subsequently digested by treatment with collagenase and trypsin-EDTA as described previously, and then were irradiated with 3000 R. Following this, varying numbers of irradiated BECs were cocultured with 2 x 105 OVA-sensitized T cells per well in RPMI 1640 medium supplemented with 10% heat inactivated FBS, 5 x 10 -5 M 2-mercaptoethanol (2ME) (Sigma), 100 U/ml penicillin, and 100 ixg/ml streptomycin. All cultures were carried out in 96-well round-bottomed microtiter plates (Coming, Tokyo, Japan). After 3 days, 0.2 p.Ci/well 2 of [3H]thymidine (The Radiochemical Center, Amersham, Japan; specific activity: 2 Ci/mmol) was added, and the cells were harvested 16 hours later to allow [3H]thymidine incorporation to be measured with a liquid scintillation counter. To assess the effect of antigenic stimulation, the [3H]thymidine-incorporation by cultures combining T cells and unpulsed BECs was subtracted from the value for cultures combining T cells and OVA-pulsed BECs.
Results
Characterization of Cultured BECs
About 30% of the freshly isolated BECs attached to the collagen substratum within 24 hours and eventually proliferated with a doubling time of 20 hours. Under phase contrast microscopy, the BECs were seen to form tightly packed monolayers of polygonal cells. Immunocytochemical staining for cytokeratin, a marker for cells of epithelial origin, was positive in more than 99% of the cultured BECs. All the cells were negative for esterase, which is considered to be a marker for macrophages. Electron microscopy showed that the cells had numerous tight junctions, desmosomes, bundles of cytoplasmic filaments, and prominent microviUi. These findings confirmed the epithelial nature of the cultured cells.
Induction of MHC Class H Antigen Expression by Cultured BECs with IFN-~I
Primary cultured BECs did not express MHC class II antigens (Fig. 1A) , whereas such antigens were readily induced on the cells by culture in the presence of IFN-~/ (Fig. 1B) . After incubation with IFN-~ for 72 hours, most z p~Ci per well. (Fig. 2) . The percent of positive cells increased in a dose-dependent manner of IFN-~/ (Fig. 3) . More than 85% of the BECs treated with 1000 U/ml of IFN-7 were positive for class II antigens, but no additional increase in positivity occurred at higher IFN-7 doses (Fig. 3) . Class II antigen expression by BECs appeared within 24 hours of treatment with 1000 U/ml of IFN-~/and then rapidly increased after 24 hours to reach a plateau at 96 hours (Fig. 4) .
Antigen-Presenting Capacity of Cultured BECs
To clarify whether the class II antigen-expressing BECs possessed an APC function, T cells obtained from OVA-sensitized rats were cocultured with OVA-pulsed BECs that were either IFN-treated or untreated. IFN-treated BECs pulsed with 1000 ~g/ml of OVA for 16 hours caused a significant increase in the proliferation of OVA-sensitized T cells (Fig. 5) BECs tended to decrease T-cell proliferation. Keyhole limpet hemocyanin (KLH)-pulsed BECs did not stimulate the proliferation of OVA-sensitized T cells (data not shown), indicating that this proliferation was antigen-specific. The response of OVA-sensitized T cells to soluble OVA was negative. The OVA-sensitized T-cell response to IFN-treated BECs increased in a dose-dependent manner, giving a peak level at 1000 ~g/ml of OVA (Fig. 6) . In contrast, IFN-treated BECs that were pulsed with 30 ~g/ml or less of OVA did not induce significant T-cell proliferation. II antigens [7, 25] . Although these data suggest that there may be additional functions of BECs, as well as acting as a barrier against inhaled pathogens, the precise roles of these cells in the local immune response or in airway inflammation are poorly understood. This study examined the regulation of class II antigen expression by cultured BECs after treatment with IFN--y and whether or not these BECs also had an APC function. For this purpose, primary rat cultured BECs were used. The BECs were shown to express cytokeratin, a marker of epithelial cells, and morphological study confirmed that they have the nature of epithelial origin. We also demonstrated that IFN-~ readily induced class II antigen expression on BECs and that the BECs bearing class II molecules were capable of presenting OVA to OVA-sensitized T cells. Thus, our results suggest that BECs may have the capacity to function as APC.
MHC class II antigens on professional APC are essential for antigen recognition by helper T cells. In this context, it has recently been demonstrated that several nonlymphoid cells, such as thyroid epithelial cells, intestinal epithelial cells, and keratinocytes, express class II antigens at various inflammatory sites [8, 16, 21] . Interestingly, in the airways, some reports have indicated that human BECs show the aberrant expression of class II antigens even in the normal adult airways [7, 14, 27] , and that enhanced expression is found in patients with bronchial asthma [25] . In the normal rat lung, class II antigen expression has been reported to be confined to dendritic cells (DC), type II alveolar cells, and lymphoepithelium of bronchus-associated lymphoid tissue [9, 13, 31] . In vitro, IFN-~/has been found to induce the expression of class II antigens by several kinds of cells that normally do not express these antigens [1, 24, 33] . In the case of BECs, however, the regulation of class II antigen expression by cytokines and the function of these antigens remain unknown.
Our study revealed that primary cultured BECs do not express class II antigens, but that IFN-~/treatment elicits a rapid and dose-dependent induction of class II antigen expression. These findings suggest that a variety of pathological conditions causing the local production of IFN-~/in the airways may lead to the induction or enhancement of class-II antigen expression by BECs.
The functional capacity of these aberrantly expressed class II antigens on nonprofessional APC remains controversial. To cite conflicting examples, in humans, primary thyroid epithelial cells expressing class II antigens have been reported to be capable of stimulating several T-cell clones specific for virus or unknown self-antigens [17] , whereas such cells could not stimulate allogeneic T cells, antigen-specific T-cell clones, or hybridomas in a mouse system [4] . In addition, although it has been reported that rat astrocytes bearing class II molecules are able to induce the proliferation of antigen-specific T cells [5] , another study indicated that the same cells did not elicit a T-cell response [19] . These conflicting results regarding the nonprofessional APC may be attributable to various factors, including the nature of the responding T cells and the species and strains employed. Of further interest, it has also been found recently that class II expressing nonlymphoid cells, such as keratinocytes in the skin, Muller cells in the retina, and beta cells in the pancreas, induce a state of antigen-specific unresponsiveness of helper T-cell clones [2, 6, 18] . The reason for these phenomena may be that such cells are unable to provide the costimulatory signals that are required for T-cell proliferation. Thus, class II antigen expression alone appears to be insufficient to allow the presentation of antigens to T cells and subsequent antigen-specific T-cell proliferation.
In the lungs, recent studies have demonstrated that human BECs obtained from clinical specimens can stimulate alloreactive T cells [14, 27] . However, the possibility exists that the BECs were contaminated by other accessory cells, such as macrophages and DC. Moreover, none of the previous reports showed that BECs could present native protein antigens to antigen-specific sensitized T cells. In this study, however, we were able to demonstrate that BECs bearing class II molecules were capable of presenting OVA to OVAsensitized T cells. These findings thus suggest that BECs may be able to process foreign antigens entering the airways and present relevant peptides to the submucosal or intraepithelial T cells.
With respect to other accessory cell populations in the airways, recent studies have focused attention on the potential role of DC in rats [13, 26, 28] . It has been shown that the epithelium of the normal rat airways has a highly developed network of DC [12, 13, 28] . DC exhibit a strong antigen-presenting capacity in vitro [12, 13, 26] , whereas alveolar macrophages have a poor accessory capacity and even suppress the T-cell proliferation induced by DC in rats [10, 11, 26] . These findings suggest that DC may be the principal accessory cells in the airways. Additionally, the present study demonstrated that rat BECs expressing class II antigens could also have an antigen-presenting function in vitro. However, the functional differences or the relationship between DC and BECs bearing class II molecules in APC capacity are unclear. Since DC constitutively express class II antigens and BECs are negative for these antigens in the normal rat lung, DC may play a significant role in presenting antigens in the normal state. However, under pathological conditions leading to the induction of class-II antigen expression by BECs, these cells may also act as APC together with DC and other accessory cells. In the human lung, although DC are widely distributed within the large airways, the lung parenchyma, and the pleura, the airway epithelium contains a relatively small number of intraepithelial DC [28, 29] . In addition, class II antigen expression by human BECs has been demonstrated even in the normal state [7, 14, 27] . Thus, human BECs may play a more important role in presenting antigens when compared with those in the rat lung. To elucidate the precise role of BECs in antigen presentation among those of other accessory cells in the airways, further studies are needed.
Finally, the present study indicates that BECs are capable of presenting an intact protein antigens to sensitized T cells in vitro, suggesting the possibility that BECs may belong to the cell population responsible for APC function in the lung. This also leads us to speculate that some clinical conditions that may cause local production of IFN-~/from T cells could enhance the class II antigen expression on BECs, thereby resulting in the modulation of the mucosal immune response in the airway through antigen presentation.
